Evidence check: Triglyceride senken in the context of Blutzucker

Lowering triglycerides in the context of blood sugar is a well-supported but multifactorial relationship. Elevated fasting triglycerides often co-occur with high fasting glucose and insulin resistance (atherogenic dyslipidemia). Improving insulin sensitivity—through weight loss, reduced carbohydrate intake (especially avoiding sugar and refined carbs), and regular physical activity—typically lowers both parameters. Omega-3 fatty acids (EPA/DHA) can reduce triglycerides but have only a minor effect on blood sugar. Evidence comes from human intervention studies and meta-analyses; however, individual genetic variants (e.g., in APOA5, LPL, GCKR) and the gut microbiome modulate the response. A DNA test alone cannot guarantee personalized triglyceride reduction; lifestyle intervention remains central. Caveat: Severely elevated triglycerides (>500 mg/dL) require medical evaluation due to pancreatitis risk. Combining blood sugar control with triglyceride lowering is reasonable, but no single biomarker replaces comprehensive risk assessment.